Lidexa
Cream · Topical
Uses
Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
Dosage and administration
For topical use only. Apply to the affected area 3 to 4 times daily or as directed by a healthcare provider.
Contraindications
Lidexa™ is contraindicated in patients with known hypersensitivity to lidocaine or any component of the formulation.
Warnings
For external use only. Not for ophthalmic use. Avoid contact with eyes. Excessive application may result in increased systemic absorption. Keep out of reach of children.
Precautions
Use only as directed. If irritation occurs, discontinue use and consult a healthcare provider. General Drug Interactions Carcinogenesis, Mutagenesis, Impairment of Fertility Pregnancy Nursing Mothers Pediatric Use
Side effects
Localized skin reactions such as redness, irritation, or rash may occur.
Drug interactions
Drug Interactions
Pregnancy
Pregnancy
Pediatric use
Pediatric Use
Description
Lidexa™ (Lidocaine Hydrochloride) Cream 38.8
How supplied
Lidexa™ (Lidocaine Hydrochloride 38.8 mg/g) is supplied as a white topical cream in a 3 oz (85 g) tube. NDC 85477-330-07
Label text from the FDA structured product label by Oncora Pharma, LLC (revised Feb 27, 2026). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Lidocaine in 1 product
Lidexa NDC products (1)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 85477-330 | Lidocaine 38.8 mg/g Cream | Oncora Pharma, LLC | UNAPPROVED DRUG OTHER |
Frequently asked questions
What is Lidexa used for?
Lidexa™ is indicated for topical analgesia as directed by a healthcare provider.
What are the side effects of Lidexa?
Localized skin reactions such as redness, irritation, or rash may occur. See the full label for the complete list.
Who makes Lidexa?
Lidexa is listed by 1 labeler in the FDA NDC directory, including Oncora Pharma, LLC.